Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04311710
Title A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types (CheckMate 76U)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb

hepatocellular carcinoma

transitional cell carcinoma

lung non-small cell carcinoma

renal cell carcinoma



Ipilimumab + Nivolumab

Ipilimumab + Nivolumab + rHuPH20

Age Groups: senior | adult
Covered Countries USA | ITA

Facility Status City State Zip Country Details
Hartford Hospital Hartford Connecticut 06106 United States Details
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 United States Details
Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapie Napoli 80131 Italy Details
Humanitas-U.O di Oncologia medica ed Ematologia Rozzano 20089 Italy Details
ospedale le scotte-U.O.C. Immunoterapia Oncologica Siena 53100 Italy Details
Local Institution Auckland 1023 New Zealand Details
*Shaded cells indicate that there was no data available from for the field